Substance-P antagonists: a new treatment for depression?

Lancet. 1998 Nov 21;352(9141):1644-6. doi: 10.1016/S0140-6736(05)61444-4.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Anxiety Disorders / drug therapy*
  • Aprepitant
  • Depressive Disorder / drug therapy*
  • Double-Blind Method
  • Humans
  • Morpholines / therapeutic use*
  • Paroxetine / therapeutic use*
  • Psychiatric Status Rating Scales
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Substance P / antagonists & inhibitors*

Substances

  • Antidepressive Agents, Second-Generation
  • Morpholines
  • Serotonin Uptake Inhibitors
  • Aprepitant
  • Substance P
  • Paroxetine